Get started
OraSure Technologies, Inc.OO

OraSure Technologies, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

OSUR trade ideas

OSUR breakout Bullish Wedge 35% upside MinimumOSUR missed earnings by .03, but gave upward guidance with Emergency Use Act submission for rapid COVID tests. The upward wedge/channel has a 35% higher top from current levels and around a 30 day periodicity. Healthcare is a defensive play, and these guys have low debt. Reopening will require a lot more testing to confirm. I think it could break up from the wedge, but I see a 30+% profit target either way *NOT FINANCIAL ADVICE - NOT A FINANCIAL ADVISOR*
NLong
by N0tSwift
2
$OSUR OraSure Technologies, Inc. Gap Fill Targets OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
NLong
by DEXWireNews
1
$OSUR can fall in the next daysContextual immersion trading strategy idea. OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The share price fell after the company announced the pricing of an underwritten offering of 8,000,000 shares of its common stock at a price of $11.00 per share. The demand for shares of the company still looks lower than the supply. So I opened a short position from $11,93; Information about stop-loss and take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NShort
by KozakHlib
OSUR reports plans of developing the in-home Covid-19 self-test Hello, What is OSUR? Orasure Technologies is a Bethlehem, Pennsylvania based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test News Stephen Tang -- President and Chief Executive Officer Reports; I have never been prouder to lead our exceptional company. OraSure has a storied history of rising to the occasion of challenging health circumstances, having developed high-quality diagnostic tests for HIV, HCV and Ebola. As you can imagine, we are doing everything we can to bring our expertise with infectious disease diagnostics in sample collection to the battle against COVID-19. On the testing front, we are developing a pan-SARS coronavirus rapid antigen in-home self-test that uses oral fluid samples and an ELISA-based test for the detection of human anti-SARS-CoV-2 antibodies in oral fluid specimens. Our molecular solutions business unit is working with laboratories and researchers to demonstrate the effectiveness of our sample collection technologies for coronavirus testing. Later in the call, I will update you on our progress on these items. Turning to the first quarter. I'm pleased to report that OraSure is off to a good start in 2020 with solid financial results. My thoughts I have identified a triangle on the monthly chart and have decided to publish this chart from a monthly perspective. It is clear that the past 2 months we have been trending down and will most likely be looking to test for some support. The triangle itself is bearish but triangles are tricky and given the news, if this company develops this in-home Covid-19 self-test and it becomes a hit, well this triangle will become bullish no doubt. Good Luck, Cheers! Be sure to comment, follow, like, and check out my profile for more trade ideas!
NLong
by keifer
$OSUR: Strong base after a 49% decline...I think this is once again an interesting name to buy back here...I recall @timwest pointing it out in early 2016, near the very bottom before a huge rally. We were bullish on it at the right time, and I think it's the right time once again. Fundamentals for the stock are a bit convoluted, with self diagnostic kits segment being highly competitive, and sales slumping, but the chart shows renewed interest in the stock from big buyers, given the accumulation base after a strong climb a month ago. I would assume some interesting news is about to come out, that might be the catalyst to push it up from this base... I'll be a buyer on signs of strength, if it breaks up from here soon. Keeping an eye on it. Cheers, Ivan Labrie.
NLong
by IvanLabrie
OSUR: More long term picksThis one is one of Tim West's findings. After exhaustive technical analysis on my part, I noticed we had a great chance to enter right at the start of a quarterly rally in the stock, so I took the plunge recently, ahead of earnings, at 8.87. I reduced my position to 3%, down from 13% to book some profit and in case we get a dip to add back to longs. I did swap some of it for other positions, to improve my portfolio, so, it's all good. Naturally, Tim's stock picking prowess once again shined here. The chart here is really constructive, and you could jump in here, on any setback, or even on a breakout of the earning day high perhaps. I'd reccomend entering a position gradually, if you're interested in riding the long term advance to $24. Buy each day for 2 weeks to a month, until you complete your desired exposure to the stock. Size is up to you and your preferred risk parameters. Good luck, Ivan Labrie.
NLong
by IvanLabrie
1